In gastric cancer, METTL14 was reported to be able to modulate the m6A modifications on circORC5 and thus abate the cell growth by the miR-30c-2-3p/AKT1 substrate 1 (AKT1S1) axis [55]. This evidence concerns the gene AKT1S1 and gastric cancer.